In clinical practice, semaglutide is also used for long-term weight management in people with overweight or obesity when medically appropriate, because it can reduce appetite and help lower calorie intake
Can individuals expect to manage their weight without long-term reliance on medication
Clinical evidence suggests that extended use of GLP-1 medications is safe and effective, with patients maintaining weight loss for years when they remain on treatment
The pharmacokinetic data is documented: Tirzepatide can roughly double the time food takes to leave the stomach during the first 4 weeks of treatment
Injection site reactions are relatively common with subcutaneous biologics and typically manifest as erythema, swelling, pruritus, or mild discomfort at the injection site
Gaining Weight on Ozempic: Causes, Solutions and When to See Your GP Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes management, typically associated with weight loss